| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/17/2006 | US20060183887 Human monoclonal antibodies to epidermal growth factor receptor |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183884 Compounds and methods for modulating cell adhesion |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183678 Nogo a binding molecules and pharmaceutical use thereof |
| 08/17/2006 | US20060183245 Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL |
| 08/17/2006 | US20060183225 producing antibodies by contacting chicken-derived B cells in which gene conversion occurs at an immunoglobulin locus with an amount of a histone deacetylase inhibitor effective for relaxing the chromatin structure of chromosomes |
| 08/17/2006 | US20060183195 Transgenic non-human animals for producing heterologous antibodies |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183176 Method and reagent for detecting cell death |
| 08/17/2006 | US20060183169 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 08/17/2006 | US20060183158 Novel gene and use thereof |
| 08/17/2006 | US20060183154 Human ring specific BNP antibodies |
| 08/17/2006 | US20060183131 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/17/2006 | US20060183121 Chimeric autoprocessing polypeptides and uses thereof |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182751 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 08/17/2006 | US20060182750 Process for preparing stable drug conjugates |
| 08/17/2006 | US20060182748 Method of creating antivenom using Emus |
| 08/17/2006 | US20060182747 Treatment of autism |
| 08/17/2006 | US20060182746 Binding to monoclonal antibody; antitumor agents |
| 08/17/2006 | US20060182745 Tetraspanin specific immunoglobulin for use in treatment and prevention of allergic disorders; immunotherapy |
| 08/17/2006 | US20060182744 Anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof |
| 08/17/2006 | US20060182741 Use of adcc-optimized antibodies for treating weak patients |
| 08/17/2006 | US20060182740 Buffered formulations for concentrating antibodies and methods of use thereof |
| 08/17/2006 | US20060182739 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest |
| 08/17/2006 | US20060182730 Antiobesity agent using hen's egg antibody against digestive enzymes |
| 08/17/2006 | US20060182714 Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides |
| 08/17/2006 | US20060182684 non-invasive and flexible method and carrier for drug delivery across the blood-brain barrier; brain tumors, brain metastases, stroke, schizophrenia, epilepsy, Alzheimer's, Parkinson's and Huntington's disease |
| 08/17/2006 | CA2597754A1 Methods and uses of antibodies in the purification of interferon |
| 08/17/2006 | CA2597265A1 Anti-interferon alpha monoclonal antibodies and methods for use |
| 08/17/2006 | CA2597098A1 Antibodies to tgfbeta |
| 08/17/2006 | CA2597044A1 5-fluoro-uracil immunoassay |
| 08/17/2006 | CA2596925A1 Method for improving expression level and stability of antibody |
| 08/17/2006 | CA2596621A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs |
| 08/17/2006 | CA2596390A1 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 08/17/2006 | CA2595395A1 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 08/17/2006 | CA2572289A1 Anti-mcp-1 antibodies, compositions, methods and uses |
| 08/17/2006 | CA2570373A1 Il-13 binding agents |
| 08/17/2006 | CA2569561A1 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
| 08/16/2006 | EP1691198A1 Method of detecting hepatitis c virus |
| 08/16/2006 | EP1691197A2 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 08/16/2006 | EP1690939A2 Novel G protein-coupled receptor proteins |
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690875A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 08/16/2006 | EP1690873A2 Composition and methods for the diagnosis of tumours |
| 08/16/2006 | EP1690872A2 Composition and methods for the diagnosis of tumours |
| 08/16/2006 | EP1690870A1 Marker peptide for alzheimer's disease |
| 08/16/2006 | EP1690550A1 Therapeutic agent for mesothelioma |
| 08/16/2006 | EP1690548A2 Cell cycle progression proteins |
| 08/16/2006 | EP1690547A1 Prevention and treatment of amyloidogenic disease |
| 08/16/2006 | EP1690094A1 Screening assay and treatment |
| 08/16/2006 | EP1689888A2 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 08/16/2006 | EP1689867A1 Immunization against chlamydia infection |
| 08/16/2006 | EP1689866A2 Msp-3-like family of genes |
| 08/16/2006 | EP1689786A2 Methods and agents for immune modulation and methods for identifying immune modulators |
| 08/16/2006 | EP1689785A2 Use of metallic cations to improve functional activity of antibodies |
| 08/16/2006 | EP1689783A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2006 | EP1689782A1 Anti-igfr1 antibody therapeutic combinations |
| 08/16/2006 | EP1689781A2 Antibodies to cd44 glycoforms and uses thereof |
| 08/16/2006 | EP1689780A2 Tissue repair by modulation of beta-1 integrin biological function |
| 08/16/2006 | EP1689779A2 Native immunoglobulin binding reagents and methods for making and using same |
| 08/16/2006 | EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof |
| 08/16/2006 | EP1689448A2 Improved method for preparing conjugates of proteins and chelating agents |
| 08/16/2006 | EP1689435A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 08/16/2006 | EP1689432A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/16/2006 | EP1689421A1 Selective neuropeptide y2 receptor agonists |
| 08/16/2006 | EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 08/16/2006 | EP1627081A4 Use of jag2 expression in diagnosis of plasma cell disorders |
| 08/16/2006 | EP1495112B1 Cell culture medium |
| 08/16/2006 | EP1401497A4 Methods for the modulation of il-13 |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1297013B1 Use of taci as an anti-tumor agent |
| 08/16/2006 | EP1272525B1 Novel antibodies specifically identifying unbound inactive psa, and uses thereof |
| 08/16/2006 | EP1252192B1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2006 | EP1186301B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 08/16/2006 | EP1135685B1 Methods for quantitation of hla-dr and cd11b |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP1064309B1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820027A Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 08/16/2006 | CN1820026A Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors |
| 08/16/2006 | CN1820023A Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 08/16/2006 | CN1819837A TAMANDARIN analogs and fragments thereof and methods of making and using |
| 08/16/2006 | CN1818066A Food-poisoning fungus concatenated fusion mycinamicin and use thereof |
| 08/16/2006 | CN1817906A Antibody against human parathormone related peptides |
| 08/16/2006 | CN1817905A IgY+IgY(Delta Fe) (H+L) horseradish peroxidase marker antibody |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269530C Antibody-dye conjugates for binding to target structures of angiogenesis in order to introperatively depict tumor peripheries |